Nexien BioPharma, Inc.
NXEN · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $35 | $117 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $8 | $8 | $8 |
| Total Curr. Assets | $4 | $43 | $125 | $26 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4 | $43 | $125 | $26 |
| Liabilities | – | – | – | – |
| Payables | $53 | $24 | $20 | $6 |
| Short-Term Debt | $312 | $271 | $222 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $20 |
| Total Curr. Liab. | $365 | $295 | $242 | $39 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | -$197 | $13,775,000 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $365 | $295 | $242 | $39 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $6 | $6 | $6 |
| Retained Earnings | -$11,534 | -$11,295 | -$10,933 | -$10,307 |
| AOCI | $0 | $51 | $51 | -$188 |
| Other Equity | $11,166 | $10,986 | $10,759 | $10,476 |
| Total Equity | -$361 | -$252 | -$118 | -$14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4 | $43 | $125 | $26 |
| Net Debt | $308 | $236 | $105 | -$5 |